Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Roemerine is a natural aporphine alkaloid primarily isolated from the leaves of *Nelumbo nucifera* (Sacred Lotus) and other plants. It is extensively researched for its potent antineoplastic and antimicrobial properties. In the context of oncology, roemerine has demonstrated significant anti-prostate cancer effects by inhibiting cell proliferation and inducing apoptosis in various cell lines, including DU145, LNCaP, and PC-3, as well as reducing tumor growth in mouse models. Its mechanism of action involves the inhibition of the PI3K/Akt signaling pathway and potential DNA intercalation. Additionally, roemerine acts as an antimicrobial agent by functioning as an efflux pump inhibitor, which can help reverse multidrug resistance in pathogens such as *Staphylococcus aureus*.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on roemerine.